What Is MEDVi? How Its GLP-1 Program Works and What It Costs

Last updated: September 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies and weight-management care. Browse all Peptides & GLP-1 education

Editorial note: PlexusDx publishes this editorial review and offers one of the programs discussed. PlexusDx is not affiliated with MEDVi and has no commercial relationship with the companies named in this article; there are no affiliate links. Information is based on the sources and dates shown.

MEDVi is a U.S. telehealth platform for weight management. It connects adults with licensed providers in its network who can prescribe compounded semaglutide or tirzepatide injections, a compounded daily GLP-1 tablet, or branded Wegovy® and Zepbound®, with medication shipped from partner pharmacies. As of September 22, 2026, MEDVi's compounded semaglutide injection is $179 for the first month for new patients, and MEDVi's refills are $299 per billing cycle as displayed on its program page; MEDVi's ongoing month-to-month rate for compounded tirzepatide injection is $399, verified September 22, 2026, and MEDVi's oral tablet runs about $70 a month over its injection rate for the same compound. PlexusDx, which publishes this explainer, offers a comparable compounded program at one flat price: PlexusDx Semaglutide Injection is $189/mo month-to-month.

What is MEDVi?

MEDVi is a direct-to-consumer telehealth brand headquartered at 131 Continental Dr., Ste 305, Newark, DE 19713, reachable at help@medvi.org, hello@medvi.org, and (323) 690-1564. Its main business is a cash-pay GLP-1 weight-management program: you fill out an online questionnaire, a licensed provider reviews it, and if you qualify a partner pharmacy ships your medication. No insurance is required, and MEDVi accepts HSA/FSA payment.

Its website also lists MEDVi Meals, skincare, hair restoration, peptide therapy options, and supplements marked "coming soon". Those products are outside the scope of this article. Everything here is drawn from MEDVi's program page, its home and start pages, and its published refund policy, all read on September 22, 2026.

One thing to be clear about up front: PlexusDx publishes this page and sells a competing GLP-1 program. This is an editorial explainer from a competitor, not a review by an unaffiliated party. Where PlexusDx is mentioned, its figures come from its own product pages, and MEDVi's figures come from MEDVi's official pages only.

What MEDVi does and what clinicians and pharmacies do

It helps to separate three roles that get blurred in marketing copy. MEDVi, the platform, handles the questionnaire, billing, support, and coordination. It is not a clinic, and its public pages do not name the medical group that employs or contracts its providers. Prescriptions are issued by licensed providers in MEDVi's network, and the prescribing decision belongs to that provider, not to MEDVi.

The medication itself comes from pharmacies MEDVi names on its program page: Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding. For the compounded programs, these are compounding pharmacies preparing semaglutide or tirzepatide to an individual prescription. For the branded track, the FDA-approved product is dispensed and billed separately from a monthly membership fee.

The division of labor matters for two reasons. First, a licensed pharmacy and a licensed prescriber do not make a compounded drug FDA-approved; compounded semaglutide and tirzepatide are not FDA-approved products and are not generic or equivalent versions of Wegovy®, Ozempic®, Zepbound® or Mounjaro®. The FDA's statement on unapproved GLP-1 drugs explains why. Second, questions about your dose, side effects, or whether to continue belong to your prescribing provider, whichever platform you use.

Medication options: injections, tablets, and branded routes

MEDVi's weight-loss menu has three distinct groups. The table lists each as MEDVi presents it, with its regulatory status and whether a public price was visible on September 22, 2026.

PlexusDx publishes this comparison and offers one of the programs discussed. Information is based on the sources and dates shown.

Checked September 22, 2026. MEDVi's semaglutide refill rate is recorded as displayed, and its tirzepatide ongoing rate was verified on its plan-selection screen the same day; confirm both in MEDVi's official offer.

Brand-drug clinical-trial results do not establish identical outcomes for a compounded injection or a compounded tablet. That is not a criticism of MEDVi specifically; it applies to every compounded GLP-1 program, including PlexusDx's. It is simply the reason to know which group your prescription falls into before you compare prices.

What enrollment and ongoing care involve

Enrollment starts with MEDVi's online questionnaire covering weight, health history, and current medications. A licensed provider in MEDVi's network reviews it and decides whether a GLP-1 prescription is appropriate. Approval is not guaranteed, and MEDVi's refund policy provides a full refund if you are medically disqualified or if you cancel within the first 72 hours without receiving services. Consult fees are otherwise non-refundable.

If approved, the prescription goes to one of MEDVi's named pharmacies, which prepares and ships it with free shipping. MEDVi describes the compounded program as including physician review, a personalized plan, 1:1 guidance, a metabolic report, free dietitian visits and care coaching, and unlimited 24/7 support. Those inclusions are a genuine differentiator; several competitors charge for coaching or do not offer it.

Billing is a recurring subscription. MEDVi asks that cancellations be requested at least 72 hours before the next billing date, by email to hello@medvi.org or through its portal chat, and service continues to the end of the current billing cycle. Its policy states that no refund is issued for the month in which cancellation occurs, that prescription medication cannot be returned, and that multi-month plans are refundable only for months with no medication shipped. MEDVi does not publish the length of its billing cycle, so "per billing cycle" is the honest unit.

Cost overview and where to find the details

MEDVi's semaglutide price pair is visible on its public pages, and its ongoing tirzepatide rate was verified on September 22, 2026; its tirzepatide first-month offer and bundle rates appear in its signup flow after the questionnaire. The table summarizes what is known and sets it beside the PlexusDx month-to-month rate for the same medication and route, then points to the post that covers each medication in depth.

Checked September 22, 2026. MEDVi totals for a new patient are the first month plus refills: three billing cycles at MEDVi come to $179 + 2 × $299 = $777, and six cycles come to $179 + 5 × $299 = $1,674. MEDVi tirzepatide refill-only totals at its ongoing $399 rate, verified September 22, 2026, are 3 × $399 = $1,197 and 6 × $399 = $2,394; a new-patient tirzepatide total is not computed because MEDVi shows its tirzepatide first-month offer after the questionnaire. PlexusDx month-to-month totals are simply the rate times the number of months: three months of PlexusDx Semaglutide Injection is $567 and six months is $1,134. PlexusDx also advertises 3- and 6-month commitment tiers at lower per-month rates; those are a different payment term and are compared separately on the head-to-head page.

Two MEDVi cost items are not published on its public pages: the tirzepatide first-month offer, which MEDVi shows after the questionnaire, and its bundle rates. MEDVi offers 3-, 6- and 12-month bundles; their rates appear in its signup flow and are not published here. The MEDVi cost guide walks through what to look for at that step.

How to evaluate legitimacy and customer feedback

"Is MEDVi legit" is one of the most common searches about the brand, and the useful answer is a checklist, not a verdict. MEDVi publishes a street address, phone number, and support emails. It names the pharmacies that fill its prescriptions, which you can look up with the relevant state board of pharmacy. It publishes a cancellation and refund policy with specific windows. Its providers are licensed clinicians, and you can ask for your provider's name and license state before you pay.

What MEDVi does not publish is also informative: the medical group behind its providers, the list of states it serves (its terms direct you to contact help@medvi.org), its tirzepatide first-month offer and tablet total, and its billing-cycle length. None of those omissions makes the company illegitimate, but each is a question to settle before you enroll. The Is MEDVi Legit? post goes through each check in order.

On customer feedback, publicly posted MEDVi customer reviews on third-party sites describe a mix of experiences: some reviewers praise the price and support responsiveness, while some reviewers report shipping delays or billing disputes. Those reviews are self-selected, unverified, and not a measure of clinical quality. MEDVi's own "1-2 lbs per week" language is marketing, and no program can promise a specific result.

MEDVi or an alternative: what should you compare?

MEDVi is one of many cash-pay GLP-1 telehealth programs, and several of them offer compounded pathways too. The fair way to compare is on observable features: the recurring price for the same medication and route, whether a separate membership fee applies, whether compounded and branded options exist, and how broadly the program is available. The table lists MEDVi beside named alternatives using only figures visible on their official pages on September 22, 2026.

Checked September 22, 2026. Recurring rates are the comparison basis; each first-month rate shown is a labeled part of that provider's standard published offer. Compounded and branded products are different products and are not interchangeable rows. Prices in this category change often; confirm each provider's current offer before enrolling.

Beyond price, three questions separate these programs. Do you want included coaching? MEDVi's free dietitian visits and 24/7 support stand out; PlexusDx does not advertise a coaching add-on. Do you want to pay nothing until a provider approves you? PlexusDx charges $0 until your provider approves your prescription and lets you cancel month-to-month with no fees; MEDVi's consult fees are non-refundable unless you are medically disqualified. Do you need a branded product? MEDVi, Hims/Hers, and Ro offer one; PlexusDx does not. For the two-provider decision in full, see MEDVi vs PlexusDx: Compare GLP-1 Prices, Plans, and Support.

A note on genetics (optional)

PlexusDx offers compounded semaglutide and tirzepatide through its Weight Management Protocols. Separately, and only if it interests you, the GLP-1 & Peptide Pathways Genetic Test ($298) analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, MC4R and TCF7L2 that relate to appetite and glucose-handling pathways. It does not predict how you will respond to any medication and does not tell you which drug, dose or provider is right for you; it is context for a conversation with your clinician. Test before you invest, and treat genetics as a guide, not a guarantee.

This article is educational. PlexusDx is not affiliated with MEDVi and has no commercial relationship with the companies discussed. PlexusDx offers compounded semaglutide and tirzepatide through its own Weight Management Protocols; this article compares approaches in the GLP-1 telehealth space. The GLP-1 & Peptide Pathways Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not predict response to any specific medication and does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol. Compounded semaglutide and tirzepatide are not FDA-approved drug products; they are prepared by state-licensed compounding pharmacies under federal compounding rules and are not the same as Wegovy®, Ozempic®, Zepbound® or Mounjaro®. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company; Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. PlexusDx is not affiliated with or endorsed by either company.

Frequently Asked Questions

What is MEDVi?

MEDVi is a U.S. telehealth platform for weight management, based in Newark, Delaware. It connects adults with licensed providers in its network who can prescribe compounded semaglutide or tirzepatide injections, a compounded GLP-1 tablet, or branded Wegovy and Zepbound. Medication is shipped from partner pharmacies MEDVi names on its site. No insurance is required, and HSA/FSA payment is accepted.

Is MEDVi a doctor or a pharmacy?

Neither. MEDVi is the platform that runs the questionnaire, billing, and support. Prescriptions are issued by licensed providers in its network, and the prescribing decision belongs to that provider. Medication is prepared and shipped by pharmacies MEDVi names on its program page: Triad Rx, RedRock Pharmacy, and Beaker Pharmacy and Compounding. MEDVi's public pages do not name its medical group.

How does MEDVi's GLP-1 program work?

You complete an online health questionnaire, a licensed provider in MEDVi's network reviews it, and if you qualify a prescription is sent to a partner pharmacy that ships your medication free. MEDVi lists physician review, a personalized plan, dietitian visits, care coaching, and 24/7 support as included. Billing recurs per cycle, and approval is never guaranteed.

How much does MEDVi cost?

As of September 22, 2026, MEDVi's compounded semaglutide injection is $179 for the first month for new patients, and MEDVi's refills are $299 per billing cycle as displayed on its program page. MEDVi's ongoing month-to-month rate for compounded tirzepatide injection is $399, verified September 22, 2026, with its tirzepatide first-month offer shown after the questionnaire; MEDVi's oral tablet runs about $70 a month over its injection rate for the same compound, with no tablet total published. Branded medication is billed as a monthly membership fee plus the medication cost. Confirm all figures in MEDVi's official offer.

Is MEDVi legit?

MEDVi publishes a street address, phone number, support emails, the names of its dispensing pharmacies, and a detailed cancellation and refund policy, and its prescriptions come from licensed providers. It does not publish its medical group, its states served, or its tirzepatide first-month offer. Publicly posted reviews describe mixed experiences and are unverified. Check those items yourself before enrolling.

What is the difference between MEDVi and PlexusDx?

Both offer compounded GLP-1 programs through licensed providers. MEDVi includes dietitian visits, coaching, and 24/7 support, accepts HSA/FSA, and offers a branded pathway. PlexusDx charges one flat month-to-month price for each medication, such as $189 for Semaglutide Injection, charges nothing until a provider approves you, and lets you cancel month-to-month with no fees. PlexusDx publishes this comparison.

Sources and dates checked

• MEDVi program page (glp1.medvi.org), read September 22, 2026
• MEDVi home page (home.medvi.org), read September 22, 2026
• MEDVi start page (start.medvi.org), read September 22, 2026
• MEDVi cancellation and refund policy, read September 22, 2026
• PlexusDx Semaglutide Injection product page, verified September 22, 2026
• PlexusDx Tirzepatide Injection product page, verified September 22, 2026
• Remedy Meds product pages, read September 22, 2026
• Noom Med pricing pages, read September 22, 2026
• OrderlyMeds pricing, read September 22, 2026
• Hims weight-loss pricing, read September 22, 2026
• Ro Body pricing, read September 22, 2026
• FDA: FDA's concerns with unapproved GLP-1 drugs used for weight loss

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. Sources and the dates they were checked are listed at the end of the article.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services, and offers compounded GLP-1 programs through its Weight Management Protocols. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.